96-43-5 | 2-Chlorothiophene

Packsize	Purity	Availability	Price	Discounted Price
25g	98%	in stock	$15.00	$10.00
100g	98%	in stock	$40.00	$28.00

Description

• Catalog Number: AB44231
• Chemical Name: 2-Chlorothiophene
• CAS Number: 96-43-5
• Molecular Formula: C4H3ClS
• Molecular Weight: 118.5846
• MDL Number: MFCD00005421
• SMILES: Clc1cccs1
• NSC Number: 8747

Computed Properties

• Complexity: 46.8
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 6
• Hydrogen Bond Acceptor Count: 1
• XLogP3: 2.5

Literature

• β-D-glucosyl conjugates of highly potent inhibitors of blood coagulation factor Xa bearing 2-chorothiophene as a P1 motif.

  ChemMedChem 20120901

• Mechanistic studies on the Pd-catalyzed direct C-H arylation of 2-substituted thiophene derivatives with arylpalladium bipyridyl complexes.

  Chemistry, an Asian journal 20120601

• Positive and negative photoion spectroscopy study of monochlorothiophenes.

  The journal of physical chemistry. A 20111013

• (2E)-1-(5-Chloro-thio-phen-2-yl)-3-(2,3-dimeth-oxy-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20111001

• (2E)-1-(5-Chloro-thio-phen-2-yl)-3-(2,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

  Acta crystallographica. Section E, Structure reports online 20110801

• Theoretical study on the electronic, structural, properties and reactivity of a series of mono-, di-, tri- and tetrachlorothiophenes as well as corresponding radical cation forms as monomers for conducting polymers.

  Chemistry Central journal 20110101

• Entering the era of non-basic p1 site groups: discovery of Xarelto (Rivaroxaban).

  Current topics in medicinal chemistry 20100101

• In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.

  Drug metabolism and disposition: the biological fate of chemicals 20090501

• Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.

  Vascular health and risk management 20081201

• Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.

  Journal of medicinal chemistry 20050922

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket.

  Journal of medicinal chemistry 20030227